Evidence map›Paper›PMID 37492496›Full record

ArticleEncephalitis (Seoul, Korea)2021

Refractory neuro-Sweet disease successfully treated with tocilizumab and mycophenolate mofetil.

Sungeun Hwang, Hyoshin Son, Jangsup Moon, Soon-Tae Lee, Keun Hwa Jung, Kyung-Il Park, Sang Kun Lee, Kon Chu

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Encephalitis (Seoul, Korea), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sungeun HwangDepartment of Neurology, Seoul National University Hospital, Seoul, Korea.
Hyoshin SonDepartment of Neurology, Seoul National University Hospital, Seoul, Korea.
Jangsup MoonDepartment of Neurology, Seoul National University Hospital, Seoul, Korea.
Soon-Tae LeeDepartment of Neurology, Seoul National University Hospital, Seoul, Korea.
Keun Hwa JungDepartment of Neurology, Seoul National University Hospital, Seoul, Korea.
Kyung-Il ParkDepartment of Neurology, Seoul National University Hospital, Seoul, Korea.
Sang Kun LeeDepartment of Neurology, Seoul National University Hospital, Seoul, Korea.
Kon ChuDepartment of Neurology, Seoul National University Hospital, Seoul, Korea.ORCID 0000-0001-5863-0302
Seoul National University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sweet syndrome, or acute febrile neutrophilic dermatosis, is mainly a dermatologic condition presenting with erythematous plaques; however, neutrophils infiltrate multiple systems. Neuro-Sweet disease is a neurological manifestation of Sweet syndrome and a rare cause of recurrent aseptic meningoencephalitis, which needs to be distinguished from neuro-Behçet disease. Although neuro-Sweet disease generally responds well to corticosteroids, relapsing neuro-Sweet disease is not an exceptional case. Herein, we present a case of a 51-year-old male with recurrent encephalitis followed by erythematous plaques. The patient was confirmed as Sweet syndrome based on skin biopsy and showed partial response to corticosteroids. With intravenous immunoglobulin, rituximab, tocilizumab, and mycophenolate mofetil, his neurologic symptoms were fully recovered.

Indexed as

Mycophenolic acidSweet syndromeTocilizumab

Identifiers

PMID37492496
PMCPMC10295875
OpenAlexW3115187974

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.